Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy ...

ARS Pharma to showcase a late-breaking oral presentation and six poster presentations highlighting real world impact of neffy® (epinephrine nasal spray) ...

Explore NotebookLM's new features, including deep research mode and data tables, designed to simplify research and improve ...

ARS Pharma to showcase a late-breaking oral presentation and six poster presentations highlighting real world impact of neffy® (epinephrine nasal spray) ...

Data from Catalent’s preclinical studies evaluating certepetide as a SMARTag® ADC payload showed both improved tumor selective penetration and efficacy BASKING RIDGE, N.J., Nov. 04, 2025 (GLOBE ...

Pemivibart has been available in the US since March 2024 under an emergency use authorisation for adults and adolescents aged ...

Perhaps the most underappreciated analyst skill is their ability to navigate “unknown unknowns.” Leaders do not always know ...

AUSTIN, Texas, Oct. 14, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients ...

An individual patient-level meta-analysis shows that tenecteplase, a next-generation thrombolytic, is at least as effective as alteplase for acute stroke — and may be superior.

Empathy is a vital leadership strength. But absorption is not empathy—it is an unrecognized drain on leadership capacity.

The degree to which someone trusts the information depicted in a chart can depend on their assumptions about who made the ...

How AI, robotics, and precision medicine are transforming cancer care—bridging hope, technology, and humanity in the ongoing ...